NCT06997068
- Conditions
- Carcinoma, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Cancer, +34 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Hypopharynx Cancer
Explore clinical trials studying Hypopharynx Cancer. Study availability and eligibility vary by location and protocol.
15 public trials
5 recruiting studies
Hypopharynx Cancer trial results
NCT06706401
- Conditions
- Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Hypopharynx Cancer, +15 more
- Locations
-
- Centre Léon Bérard Lyon, France
- Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France
- Institut Gustave Roussy Villejuif, France
- Institut de Cancérologie de l'Ouest - Paul Papin Angers, France
NCT07063212
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +29 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
NCT05337631
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +23 more
- Locations
-
- Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine Baltimore, Maryland, United States
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai New York, United States
- Department of Radiation Oncology, Case Western Reserve University Cleveland, Ohio, United States
- Division of Radiation Oncology, The Ohio State University Wexner Columbus, Ohio, United States
NCT06611137
- Conditions
- Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Hypopharynx Cancer, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Not Yet Recruiting
Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer
NCT06554028
- Conditions
- Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Hypopharynx Cancer, +12 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
NCT03082534
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +37 more
- Locations
-
- UCSD Moores Cancer Center La Jolla, California, United States
- University of California Los Angeles Cancer Center Los Angeles, California, United States
- University of Michigan Cancer Center Ann Arbor, Michigan, United States
- Washington School of Medicine Cancer Center St Louis, Missouri, United States
NCT02586207
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +25 more
- Locations
-
- UCSD Moores Cancer Center La Jolla, California, United States
- Sanford-Bismarck Medical Center Bismarck, North Dakota, United States
- Sanford-Roger Maris Cancer Center Fargo, North Dakota, United States
- Sanford Health Cancer Center Sioux Falls, South Dakota, United States
NCT03096808
- Conditions
- Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +26 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
NCT00158678
- Conditions
- Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Hypopharynx Cancer, +12 more
- Locations
-
- Centre Alexis Vautrin Vandœuvre-lès-Nancy, France
- Institut Gustave Roussy Villejuif, France